Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Coco & Wellness ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 5.4%   Bankruptcy risk   11.2% 5.0% 6.6% 7.7% 4.6% 10.5% 16.3% 12.6%   Credit score (0-100)   24 45 37 32 45 22 10 19   Credit rating   BB BBB BBB BB BBB BB BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   646 1,189 491 -23.2 407 86.1 0.0 0.0   EBITDA   -186 265 266 268 136 -95.9 0.0 0.0   EBIT   -186 187 209 210 39.8 -162 0.0 0.0   Pre-tax profit (PTP)   -186.6 186.9 207.2 209.8 134.5 -23.1 0.0 0.0   Net earnings   -186.6 186.9 207.2 169.5 81.6 -23.1 0.0 0.0   Pre-tax profit without non-rec. items   -187 187 207 210 134 -23.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   392 314 175 118 43.7 0.0 0.0 0.0   Shareholders equity total   -137 50.3 7.5 177 259 288 238 238   Interest-bearing liabilities   657 648 397 72.8 0.0 0.0 0.0 0.0   Balance sheet total (assets)   634 801 533 794 628 507 238 238   Net Debt   645 640 324 -3.7 -213 -128 -172 -172     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   646 1,189 491 -23.2 407 86.1 0.0 0.0   Gross profit growth   0.0% 83.9% -58.7% 0.0% 0.0% -78.8% -100.0% 0.0%   Employees   0 0 2 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% -100.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   634 801 533 794 628 507 238 238   Balance sheet change%   0.0% 26.5% -33.5% 49.1% -20.9% -19.3% -53.0% 0.0%   Added value   -186.4 265.5 266.4 268.1 97.6 -95.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   502 -157 -196 -116 -192 -131 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 -1.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -28.8% 15.7% 42.5% -904.6% 9.8% -187.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -24.2% 23.8% 31.3% 31.7% 19.4% -3.4% 0.0% 0.0%   ROI %   -28.4% 27.6% 37.8% 59.7% 45.5% -6.0% 0.0% 0.0%   ROE %   -29.5% 54.7% 716.9% 183.7% 37.5% -8.4% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   -9.1% 15.4% 1.4% 22.3% 41.2% 56.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -345.9% 240.9% 121.8% -1.4% -157.3% 133.3% 0.0% 0.0%   Gearing %   -481.2% 1,289.1% 5,276.9% 41.1% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.0% 0.2% 0.2% 10.4% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   0.0 0.0 0.2 0.7 1.0 1.9 0.0 0.0   Current Ratio   0.0 0.3 0.2 0.8 1.2 1.9 0.0 0.0   Cash and cash equivalent   12.5 8.6 73.0 76.5 213.3 127.9 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -757.7 -492.3 -396.5 -119.3 58.2 153.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 133 0 0 -96 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 133 0 0 -96 0 0   EBIT / employee   0 0 104 0 0 -162 0 0   Net earnings / employee   0 0 104 0 0 -23 0 0